Rafał Tarkowski

2.9k total citations · 1 hit paper
58 papers, 1.9k citations indexed

About

Rafał Tarkowski is a scholar working on Reproductive Medicine, Immunology and Obstetrics and Gynecology. According to data from OpenAlex, Rafał Tarkowski has authored 58 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Reproductive Medicine, 14 papers in Immunology and 11 papers in Obstetrics and Gynecology. Recurrent topics in Rafał Tarkowski's work include Endometriosis Research and Treatment (17 papers), Ovarian cancer diagnosis and treatment (9 papers) and Endometrial and Cervical Cancer Treatments (8 papers). Rafał Tarkowski is often cited by papers focused on Endometriosis Research and Treatment (17 papers), Ovarian cancer diagnosis and treatment (9 papers) and Endometrial and Cervical Cancer Treatments (8 papers). Rafał Tarkowski collaborates with scholars based in Poland, United States and Spain. Rafał Tarkowski's co-authors include Jan Kotarski, Wojciech Szeliga, Linda Vatan, Weiping Zou, Rebecca Liu, Ilona Kryczek, Ende Zhao, Lili Zhao, Kathleen R. Cho and Weimin Wang and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Immunity.

In The Last Decade

Rafał Tarkowski

49 papers receiving 1.9k citations

Hit Papers

Epigenetic silencing of TH1-type chemokines shapes tumour... 2015 2026 2018 2022 2015 250 500 750

Peers

Rafał Tarkowski
Rafał Tarkowski
Citations per year, relative to Rafał Tarkowski Rafał Tarkowski (= 1×) peers Abdeljabar El Andaloussi

Countries citing papers authored by Rafał Tarkowski

Since Specialization
Citations

This map shows the geographic impact of Rafał Tarkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafał Tarkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafał Tarkowski more than expected).

Fields of papers citing papers by Rafał Tarkowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafał Tarkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafał Tarkowski. The network helps show where Rafał Tarkowski may publish in the future.

Co-authorship network of co-authors of Rafał Tarkowski

This figure shows the co-authorship network connecting the top 25 collaborators of Rafał Tarkowski. A scholar is included among the top collaborators of Rafał Tarkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafał Tarkowski. Rafał Tarkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tarkowski, Rafał, et al.. (2025). Mechanistic Insights into the Anti-Inflammatory and Anti-Proliferative Effects of Selected Medicinal Plants in Endometriosis. International Journal of Molecular Sciences. 26(22). 10947–10947.
3.
Tarkowski, Rafał, et al.. (2025). The Efficacy of Pembrolizumab Immunotherapy in the Treatment of Endometrial Cancer: A Systematic Review. International Journal of Molecular Sciences. 26(18). 8789–8789.
4.
Tarkowski, Rafał, et al.. (2025). Progestins - a review of clinical application in gynecology. Annals of Medicine. 57(1). 2570794–2570794.
5.
Кулак, А. И., et al.. (2025). Challenges in Differentiating Uterine Mesenchymal Tumors—Key Diagnostic Criteria. Journal of Clinical Medicine. 14(13). 4644–4644.
6.
Tarkowski, Rafał, et al.. (2025). Feasibility of Trastuzumab-Deruxtecan in the Treatment of Ovarian Cancer: A Systematic Review. Journal of Clinical Medicine. 14(23). 8483–8483.
7.
Rasoul-Pelińska, K, et al.. (2025). Gynecological Cancer Oncobiome Systematic Review. Cancers. 17(19). 3227–3227.
8.
Tarkowski, Rafał, et al.. (2024). Phytotherapy of Vulvovaginal Candidiasis: A Narrative Review. International Journal of Molecular Sciences. 25(7). 3796–3796. 7 indexed citations
10.
Tarkowski, Rafał, et al.. (2024). New hopes and promises in the treatment of ovarian cancer focusing on targeted treatment—a narrative review. Frontiers in Pharmacology. 15. 1416555–1416555. 9 indexed citations
11.
Pawłowska, Anna, et al.. (2023). Expression of Gal-9 on Dendritic Cells and Soluble Forms of TIM-3/Gal-9 in Patients Suffering from Endometriosis. International Journal of Molecular Sciences. 24(6). 5948–5948. 9 indexed citations
12.
Tarkowski, Rafał, et al.. (2023). Gonadotropin-Releasing Hormone Antagonists—A New Hope in Endometriosis Treatment?. Journal of Clinical Medicine. 12(3). 1008–1008. 14 indexed citations
13.
Tarkowski, Rafał, et al.. (2023). Treatment of Vulvovaginal Candidiasis—An Overview of Guidelines and the Latest Treatment Methods. Journal of Clinical Medicine. 12(16). 5376–5376. 31 indexed citations
14.
Misiek, Marcin, et al.. (2023). Perioperative Factors Affecting the Healing of Rectovaginal Fistula. Journal of Clinical Medicine. 12(19). 6421–6421. 1 indexed citations
15.
Tarkowski, Rafał, et al.. (2023). Possible Correlation between Urocortin 1 (Ucn1) and Immune Parameters in Patients with Endometriosis. International Journal of Molecular Sciences. 24(9). 7787–7787.
16.
Tarkowski, Rafał, et al.. (2023). The impact of endometriosis on depressive and anxiety symptoms and quality of life: a systematic review. Frontiers in Public Health. 11. 1230303–1230303. 25 indexed citations
17.
Tarkowski, Rafał, et al.. (2022). Future Perspectives of Ectopic Pregnancy Treatment—Review of Possible Pharmacological Methods. International Journal of Environmental Research and Public Health. 19(21). 14230–14230. 16 indexed citations
18.
Pawłowska, Anna, et al.. (2020). <p>Programmed Death-1 Receptor (PD-1) as a Potential Prognosis Biomarker for Ovarian Cancer Patients</p>. Cancer Management and Research. Volume 12. 9691–9709. 13 indexed citations
19.
Peng, Dongjun, Ilona Kryczek, Nisha Nagarsheth, et al.. (2015). Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy. Nature. 527(7577). 249–253. 893 indexed citations breakdown →
20.
Polak, Grzegorz, Iwona Wertel, Maria Kozioł-Montewka, Rafał Tarkowski, & Jan Kotarski. (2003). Investigation of glutathione concentrations in peritoneal fluid from women with and without endometriosis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 109(2). 206–208. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026